In vitro metabolism of an estrogen-related receptor γ modulator, GSK5182, by human liver microsomes and recombinant cytochrome P450s

Jeongmin Joo, Zhexue Wu, Boram Lee, Jong Cheol Shon, Taeho Lee, In Kyu Lee, Taebo Sim, Kyung Hee Kim, Nam Doo Kim, Seong Heon Kim, Kwang Hyeon Liu

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

GSK5182 (4-[(Z)-1-[4-(2-dimethylaminoethyloxy)phenyl]-hydroxy-2-phenylpent-1-enyl]phenol) is a specific inverse agonist for estrogen-related receptor γ, a member of the orphan nuclear receptor family that has important functions in development and homeostasis. This study was performed to elucidate the metabolites of GSK5182 and to characterize the enzymes involved in its metabolism. Incubation of human liver microsomes with GSK5182 in the presence of NADPH resulted in the formation of three metabolites, M1, M2 and M3. M1 and M3 were identified as N-desmethyl-GSK5182 and GSK5182 N-oxide, respectively, on the basis of liquid chromatography-tandem mass spectrometric (LC-MS/MS) analysis. M2 was suggested to be hydroxy-GSK5182 through interpretation of its MS/MS fragmentation pattern. In addition, the specific cytochrome P450 (P450) and flavin-containing monooxygenase (FMO) isoforms responsible for GSK5182 oxidation to the three metabolites were identified using a combination of correlation analysis, chemical inhibition in human liver microsomes and metabolism by expressed recombinant P450 and FMO isoforms. GSK5182 N-demethylation and hydroxylation is mainly mediated by CYP3A4, whereas FMO1 and FMO3 contribute to the formation of GSK5182 N-oxide from GSK5182. The present data will be useful for understanding the pharmacokinetics and drug interactions of GSK5182 in vivo.

Original languageEnglish
Pages (from-to)163-173
Number of pages11
JournalBiopharmaceutics and Drug Disposition
Volume36
Issue number3
DOIs
Publication statusPublished - 2015 Apr 1

Fingerprint

Estrogen Receptor Modulators
Liver Microsomes
Cytochromes
dimethylaniline monooxygenase (N-oxide forming)
Oxides
Protein Isoforms
In Vitro Techniques
GSK5182
Orphan Nuclear Receptors
Cytochrome P-450 CYP3A
Hydroxylation
Phenol
Nuclear Family
NADP
Drug Interactions
Liquid Chromatography
Cytochrome P-450 Enzyme System
Estrogens
Homeostasis
Pharmacokinetics

Keywords

  • cytochrome P450
  • flavin-containing monooxygenase
  • GSK5182
  • microsomes
  • oxidation

ASJC Scopus subject areas

  • Pharmacology (medical)
  • Pharmaceutical Science
  • Pharmacology

Cite this

In vitro metabolism of an estrogen-related receptor γ modulator, GSK5182, by human liver microsomes and recombinant cytochrome P450s. / Joo, Jeongmin; Wu, Zhexue; Lee, Boram; Shon, Jong Cheol; Lee, Taeho; Lee, In Kyu; Sim, Taebo; Kim, Kyung Hee; Kim, Nam Doo; Kim, Seong Heon; Liu, Kwang Hyeon.

In: Biopharmaceutics and Drug Disposition, Vol. 36, No. 3, 01.04.2015, p. 163-173.

Research output: Contribution to journalArticle

Joo, J, Wu, Z, Lee, B, Shon, JC, Lee, T, Lee, IK, Sim, T, Kim, KH, Kim, ND, Kim, SH & Liu, KH 2015, 'In vitro metabolism of an estrogen-related receptor γ modulator, GSK5182, by human liver microsomes and recombinant cytochrome P450s', Biopharmaceutics and Drug Disposition, vol. 36, no. 3, pp. 163-173. https://doi.org/10.1002/bdd.1929
Joo, Jeongmin ; Wu, Zhexue ; Lee, Boram ; Shon, Jong Cheol ; Lee, Taeho ; Lee, In Kyu ; Sim, Taebo ; Kim, Kyung Hee ; Kim, Nam Doo ; Kim, Seong Heon ; Liu, Kwang Hyeon. / In vitro metabolism of an estrogen-related receptor γ modulator, GSK5182, by human liver microsomes and recombinant cytochrome P450s. In: Biopharmaceutics and Drug Disposition. 2015 ; Vol. 36, No. 3. pp. 163-173.
@article{189151ffd18b40029518cf1435d1e79f,
title = "In vitro metabolism of an estrogen-related receptor γ modulator, GSK5182, by human liver microsomes and recombinant cytochrome P450s",
abstract = "GSK5182 (4-[(Z)-1-[4-(2-dimethylaminoethyloxy)phenyl]-hydroxy-2-phenylpent-1-enyl]phenol) is a specific inverse agonist for estrogen-related receptor γ, a member of the orphan nuclear receptor family that has important functions in development and homeostasis. This study was performed to elucidate the metabolites of GSK5182 and to characterize the enzymes involved in its metabolism. Incubation of human liver microsomes with GSK5182 in the presence of NADPH resulted in the formation of three metabolites, M1, M2 and M3. M1 and M3 were identified as N-desmethyl-GSK5182 and GSK5182 N-oxide, respectively, on the basis of liquid chromatography-tandem mass spectrometric (LC-MS/MS) analysis. M2 was suggested to be hydroxy-GSK5182 through interpretation of its MS/MS fragmentation pattern. In addition, the specific cytochrome P450 (P450) and flavin-containing monooxygenase (FMO) isoforms responsible for GSK5182 oxidation to the three metabolites were identified using a combination of correlation analysis, chemical inhibition in human liver microsomes and metabolism by expressed recombinant P450 and FMO isoforms. GSK5182 N-demethylation and hydroxylation is mainly mediated by CYP3A4, whereas FMO1 and FMO3 contribute to the formation of GSK5182 N-oxide from GSK5182. The present data will be useful for understanding the pharmacokinetics and drug interactions of GSK5182 in vivo.",
keywords = "cytochrome P450, flavin-containing monooxygenase, GSK5182, microsomes, oxidation",
author = "Jeongmin Joo and Zhexue Wu and Boram Lee and Shon, {Jong Cheol} and Taeho Lee and Lee, {In Kyu} and Taebo Sim and Kim, {Kyung Hee} and Kim, {Nam Doo} and Kim, {Seong Heon} and Liu, {Kwang Hyeon}",
year = "2015",
month = "4",
day = "1",
doi = "10.1002/bdd.1929",
language = "English",
volume = "36",
pages = "163--173",
journal = "Biopharmaceutics and Drug Disposition",
issn = "0142-2782",
publisher = "John Wiley and Sons Ltd",
number = "3",

}

TY - JOUR

T1 - In vitro metabolism of an estrogen-related receptor γ modulator, GSK5182, by human liver microsomes and recombinant cytochrome P450s

AU - Joo, Jeongmin

AU - Wu, Zhexue

AU - Lee, Boram

AU - Shon, Jong Cheol

AU - Lee, Taeho

AU - Lee, In Kyu

AU - Sim, Taebo

AU - Kim, Kyung Hee

AU - Kim, Nam Doo

AU - Kim, Seong Heon

AU - Liu, Kwang Hyeon

PY - 2015/4/1

Y1 - 2015/4/1

N2 - GSK5182 (4-[(Z)-1-[4-(2-dimethylaminoethyloxy)phenyl]-hydroxy-2-phenylpent-1-enyl]phenol) is a specific inverse agonist for estrogen-related receptor γ, a member of the orphan nuclear receptor family that has important functions in development and homeostasis. This study was performed to elucidate the metabolites of GSK5182 and to characterize the enzymes involved in its metabolism. Incubation of human liver microsomes with GSK5182 in the presence of NADPH resulted in the formation of three metabolites, M1, M2 and M3. M1 and M3 were identified as N-desmethyl-GSK5182 and GSK5182 N-oxide, respectively, on the basis of liquid chromatography-tandem mass spectrometric (LC-MS/MS) analysis. M2 was suggested to be hydroxy-GSK5182 through interpretation of its MS/MS fragmentation pattern. In addition, the specific cytochrome P450 (P450) and flavin-containing monooxygenase (FMO) isoforms responsible for GSK5182 oxidation to the three metabolites were identified using a combination of correlation analysis, chemical inhibition in human liver microsomes and metabolism by expressed recombinant P450 and FMO isoforms. GSK5182 N-demethylation and hydroxylation is mainly mediated by CYP3A4, whereas FMO1 and FMO3 contribute to the formation of GSK5182 N-oxide from GSK5182. The present data will be useful for understanding the pharmacokinetics and drug interactions of GSK5182 in vivo.

AB - GSK5182 (4-[(Z)-1-[4-(2-dimethylaminoethyloxy)phenyl]-hydroxy-2-phenylpent-1-enyl]phenol) is a specific inverse agonist for estrogen-related receptor γ, a member of the orphan nuclear receptor family that has important functions in development and homeostasis. This study was performed to elucidate the metabolites of GSK5182 and to characterize the enzymes involved in its metabolism. Incubation of human liver microsomes with GSK5182 in the presence of NADPH resulted in the formation of three metabolites, M1, M2 and M3. M1 and M3 were identified as N-desmethyl-GSK5182 and GSK5182 N-oxide, respectively, on the basis of liquid chromatography-tandem mass spectrometric (LC-MS/MS) analysis. M2 was suggested to be hydroxy-GSK5182 through interpretation of its MS/MS fragmentation pattern. In addition, the specific cytochrome P450 (P450) and flavin-containing monooxygenase (FMO) isoforms responsible for GSK5182 oxidation to the three metabolites were identified using a combination of correlation analysis, chemical inhibition in human liver microsomes and metabolism by expressed recombinant P450 and FMO isoforms. GSK5182 N-demethylation and hydroxylation is mainly mediated by CYP3A4, whereas FMO1 and FMO3 contribute to the formation of GSK5182 N-oxide from GSK5182. The present data will be useful for understanding the pharmacokinetics and drug interactions of GSK5182 in vivo.

KW - cytochrome P450

KW - flavin-containing monooxygenase

KW - GSK5182

KW - microsomes

KW - oxidation

UR - http://www.scopus.com/inward/record.url?scp=84926482411&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84926482411&partnerID=8YFLogxK

U2 - 10.1002/bdd.1929

DO - 10.1002/bdd.1929

M3 - Article

VL - 36

SP - 163

EP - 173

JO - Biopharmaceutics and Drug Disposition

JF - Biopharmaceutics and Drug Disposition

SN - 0142-2782

IS - 3

ER -